Biomimetic Nanomaterials for Cancer Therapy

$40.00

Biomimetic Nanomaterials for Cancer Therapy

M.J. Macamo, M.J. Mochane, S. Mametja, J.S. Sefadi

Recently, the use of biomimetic nanoparticles in advanced cancer therapy has been intensively studied since they offer better distinctive properties relative to conventional therapeutic methods. They are categorized based on the nature of their precursors. The synthesis technique to be used need to be thoroughly studied to optimize the resulting overall properties. Several studies have indicated that these materials are efficient in applications such as cancer imaging, targeted drug delivery, immunotherapy, as well as photothermal and photodynamic therapy. However, they present challenges such as lack of standardized protocol for synthesis, scaling-up, partial enclosing of the cell membrane, and easily contaminated.

Keywords
Nanoparticles, Biomimetic, Drug Delivery, Applications, Cancer Therapy, Cargo

Published online , 32 pages

Citation: M.J. Macamo, M.J. Mochane, S. Mametja, J.S. Sefadi, Biomimetic Nanomaterials for Cancer Therapy, Materials Research Foundations, Vol. 193, pp 58-89, 2026

DOI: https://doi.org/10.21741/9781644904350-3

Part of the book on Biomimetic

References
[1] B. Liu, H. Zhou, L. Tan, K.T.H. Siu, X.Y. Guan, Exploring treatment options in cancer: Tumor treatment strategies, Sig. Transduct. Target. Ther. 9 (2024) 1- 44. https://doi.org/10.1038/s41392-024-01856-7
[2] P. He, G. Yang, D. Zhu, H. Kong, Y.R. Corrales-Ureña, L. Colombi Ciacchi, G. Wei, Biomolecule-mimetic nanomaterials for photothermal and photodynamic therapy of cancers: Bridging nanobiotechnology and biomedicine, J. Nanobiotechnol. 20 (2022) 1-32. https://doi.org/10.1186/s12951-022-01691-4
[3] L. Sapio, S. Naviglio, Innovation through Tradition: The Current Challenges in Cancer Treatment, Int. J. Mol. Sci. 23 (2022) 1-3. https://doi.org/10.3390/ijms23105296
[4] A. Alam, Chemotherapy Treatment and Strategy Schemes: A Review, Open Acc. J. Toxicol. 2 (2018) 1-4. https://doi.org/10.19080/OAJT.2018.02.555600
[5] E. Bidram, Y. Esmaeili, H. Ranji-Burachaloo, N. Al-Zaubai, A. Zarrabi, A. Stewart, D.E. Dunstan, A concise review on cancer treatment methods and delivery systems, J. Drug Deliv. Sci. Technol. 54 (2019) 1-28. https://doi.org/10.1016/j.jddst.2019.101350
[6] J.H. Schiller, D. Harrington, C.P. Belani, C. Langer, A. Sandler, J. Krook, J. Zhu, D.H. Johnson, Comparison of Four Chemotherapy Regimens for Advanced Non-Small-Cell Lung Cancer, N. Engl. J. Med. 346 (2002) 92-98. https://doi.org/10.1056/NEJMoa011954
[7] S. Kumar, Drug Targets for Cancer Treatment: An Overview, Med Chem 5 (2015) 115-123. https://doi.org/10.4172/2161-0444.1000252
[8] D.A. Jaffray, M.K. Gospodarowicz, Radiation Therapy for Cancer, In: H. Gelband, P. Jha, R. Sankaranarayanan, S. Horton (Eds.), Cancer: Disease Control Priorities, Third Edition (Volume 3), Washington (DC), The International Bank for Reconstruction and Development / The World Bank, 2015, Chapter 14.
[9] A. Shafizadeh, H. Rastegari, H. Shahbeik, H. Mobli, J. Pan, W. Peng, G. Li, M. Tabatabaei, M. Aghbashlo, A critical review of the use of nanomaterials in the biomass pyrolysis process, J. Clean. Prod. 400 (2023)136705. https://doi.org/10.1016/j.jclepro.2023.136705
[10] H. Saleem, S.J. Zaidi, Sustainable use of nanomaterials in textiles and their environmental impact, Materials 13 (2020) 1-28. https://doi.org/10.3390/ma13225134
[11] R. Qiu, F. Qian, X. Wang, H. Li, L. Wang, Targeted delivery of 20(S)-ginsenoside Rg3-based polypeptide nanoparticles to treat colon cancer, Biomed. Microdevices 21 (2019) 1-13. https://doi.org/10.1007/s10544-019-0374-0
[12] A. Aghebati-Maleki, S. Dolati, M. Ahmadi, A. Baghbanzhadeh, M. Asadi, A. Fotouhi, M. Yousefi, L. Aghebati-Maleki, Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers, J. Cell Physiol. 235 (2020) 1962-1972. https://doi.org/10.1002/jcp.29126
[13] N. Baig, M. Sajid, T.A. Saleh, Recent trends in nanomaterial-modified electrodes for electroanalytical applications, TrAC – Trends in Analytical Chemistry 111 (2019) 47-61. https://doi.org/10.1016/j.trac.2018.11.044
[14] P. Makkar, N.N. Ghosh, A review on the use of DFT for the prediction of the properties of nanomaterials, RSC Adv. 11 (2021) 27897-27924. https://doi.org/10.1039/D1RA04876G
[15] Q. Wu, W.S. Miao, Y. Du Zhang, H.J. Gao, D. Hui, Mechanical properties of nanomaterials: A review, Nanotechnol. Rev. 9 (2020) 259-273. https://doi.org/10.1515/ntrev-2020-0021
[16] S. Montalvo-Quiros, G. Aragoneses-Cazorla, L. Garcia-Alcalde, M. Vallet-Regí, B. González, J.L. Luque-Garcia, Cancer cell targeting and therapeutic delivery of silver nanoparticles by mesoporous silica nanocarriers: Insights into the action mechanisms using quantitative proteomics, Nanoscale 11 (2019) 4531-4545. https://doi.org/10.1039/C8NR07667G
[17] O. Afzal, A.S.A. Altamimi, M.S. Nadeem, S.I. Alzarea, W.H. Almalki, A. Tariq, B. Mubeen, B.N. Murtaza, S. Iftikhar, N. Riaz, I. Kazmi, Nanoparticles in drug delivery: From history to therapeutic applications, Nanomaterials 12 (2022)1-27. https://doi.org/10.3390/nano12244494
[18] M. Hegde, P. Pai, M.G. Shetty, K.S. Babitha, Gold nanoparticle based biosensors for rapid pathogen detection: A review, Environ. Nanotechnol. Monit. Manag. 18 (2022)100756. https://doi.org/10.1016/j.enmm.2022.100756
[19] M. Chehelgerdi, M. Chehelgerdi, O.Q.B. Allela, R.D.C. Pecho, N. Jayasankar, D.P. Rao, T. Thamaraikani, M. Vasanthan, P. Viktor, N. Lakshmaiya, M.J. Saadh, A. Amajd, M.A. Abo-Zaid, R.Y. Castillo-Acobo, A.H. Ismail, A.H. Amin, R. Akhavan-Sigari, Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation, Mol. Cancer 22 (2023))1-103. https://doi.org/10.1186/s12943-023-01865-0
[20] N. Hasan, M. Aftab, M. Ullah, P.T. Nguyen, R. Agustina, Y.Y. Djabir, T.A. Tockary, S. Uchida, Nanoparticle-based drug delivery system for Oral Cancer: Mechanism, challenges, and therapeutic potential, Results Chem. 14 (2025) 1-11. https://doi.org/10.1016/j.rechem.2025.102068
[21] A. Yusuf, A.R.Z. Almotairy, H. Henidi, O.Y. Alshehri, M.S. Aldughaim, Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems, Polymers (Basel) 15 (2023)1-26. https://doi.org/10.3390/polym15071596
[22] J.S. Suk, Q. Xu, N. Kim, J. Hanes, L.M. Ensign, PEGylation as a strategy for improving nanoparticle-based drug and gene delivery, Adv. Drug Deliv. Rev. 99 (2016) 28-51. https://doi.org/10.1016/j.addr.2015.09.012
[23] H. Liu, Y.Y. Su, X.C. Jiang, J.Q. Gao, Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system, Drug Deliv. Transl. Res. 13 (2023) 716-737. https://doi.org/10.1007/s13346-022-01252-0
[24] I. Diori Karidio, S.H. Sanlier, Reviewing cancer’s biology: an eclectic approach, J. Egypt Natl. Canc. Inst. 33 (2021) 1-17. https://doi.org/10.1186/s43046-021-00088-y
[25] A.C. Palmer, P.K. Sorger, Combination Cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy, Cell 171 (2017) 1678-1691. https://doi.org/10.1016/j.cell.2017.11.009
[26] X. Shi, X. Wang, W. Yao, D. Shi, X. Shao, Z. Lu, Y. Chai, J. Song, W. Tang, X. Wang, Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives, Sig. Transduct. Target. Ther. 9 (2024)192. https://doi.org/10.1038/s41392-024-01885-2
[27] U. Anand, A. Dey, A.K.S. Chandel, R. Sanyal, A. Mishra, D.K. Pandey, V. De Falco, A. Upadhyay, R. Kandimalla, A. Chaudhary, J.K. Dhanjal, S. Dewanjee, J. Vallamkondu, J.M. Pérez de la Lastra, Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics, Genes. Dis. 10 (2023) 1367-1401. https://doi.org/10.1016/j.gendis.2022.02.007
[28] O. Baykara, Current therapies and latest developments in cancer treatment, In: H.S. Watanabe (Ed), Horizons in Cancer Research, Volume 57 , Nova Science Publishers, Inc, 2015, pp.105-108.
[29] A. Saini, M. Kumar, S. Bhatt, V. Saini, A. Malik, Cancer causes and treatments, Int. J. Pharm. Sci. Res. 11 (2020) 3121-3134.
[30] H. Popper, Primary tumor and metastasis-sectioning the different steps of the metastatic cascade, Transl. Lung Cancer Res. 9 (2020) 2277-2300. https://doi.org/10.21037/tlcr-20-175
[31] J. Fares, M.Y. Fares, H.H. Khachfe, H.A. Salhab, Y. Fares, Molecular principles of metastasis: a hallmark of cancer revisited, Sig. Transduct. Target. Ther. 5 (2020) 1-17. https://doi.org/10.1038/s41392-020-0134-x
[32] X. Li, S. He, B. Ma, Autophagy and autophagy-related proteins in cancer, Mol. Cancer 19 (2020) 1-16. https://doi.org/10.1186/s12943-019-1085-0
[33] F. Salahpour Anarjan, Active targeting drug delivery nanocarriers: Ligands, Nano-Structures and Nano-Objects 19 (2019) 1-7. https://doi.org/10.1016/j.nanoso.2019.100370
[34] J. Yoo, C. Park, G. Yi, D. Lee, H. Koo, Active targeting strategies using biological ligands for nanoparticle drug delivery systems, Cancers (Basel) 11 (2019) 1-13. https://doi.org/10.3390/cancers11050640
[35] L. Shi, J. Zhang, M. Zhao, S. Tang, X. Cheng, W. Zhang, W. Li, X. Liu, H. Peng, Q. Wang, Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery, Nanoscale 13 (2021) 10748-10764. https://doi.org/10.1039/D1NR02065J
[36] M.F. Attia, N. Anton, J. Wallyn, Z. Omran, T.F. Vandamme, An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites, J. Pharm. Pharmacol. 71 (2019) 1185-1198. https://doi.org/10.1111/jphp.13098
[37] L. Zhong, Y. Li, L. Xiong, W. Wang, M. Wu, T. Yuan, W. Yang, C. Tian, Z. Miao, T. Wang, S. Yang, Small molecules in targeted cancer therapy: advances, challenges, and future perspectives, Sig. Transduct. Target. Ther. 6 (2021) 1-48. https://doi.org/10.1038/s41392-021-00572-w
[38] P.N. Navya, A. Kaphle, S.P. Srinivas, S.K. Bhargava, V.M. Rotello, H.K. Daima, Current trends and challenges in cancer management and therapy using designer nanomaterials, Nano. Converg. 6 (2019) 1-30. https://doi.org/10.1186/s40580-019-0193-2
[39] J. Li, Q. Wang, G. Xia, N. Adilijiang, Y. Li, Z. Hou, Z. Fan, J. Li, Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy, Pharmaceutics 15 (2023) 1-28. https://doi.org/10.3390/pharmaceutics15092233
[40] C. Caro, A. Avasthi, J.M. Paez-Muñoz, M. Pernia Leal, M.L. Garcia-Martin, Passive targeting of high-grade gliomas: Via the EPR effect: A closed path for metallic nanoparticles?, Biomater Sci 9 (2021) 7984-7995. https://doi.org/10.1039/D1BM01398J
[41] M.A. Rahim, N. Jan, S. Khan, H. Shah, A. Madni, A. Khan, A. Jabar, S. Khan, A. Elhissi, Z. Hussain, H.C. Aziz, M. Sohail, M. Khan, H.E. Thu, Recent advancements in stimuli responsive drug delivery platforms for active and passive cancer targeting, Cancers (Basel) 13 (2021) 1-52. https://doi.org/10.3390/cancers13040670
[42] L. Taiariol, C. Chaix, C. Farre, E. Moreau, Click and Bioorthogonal Chemistry: The Future of Active Targeting of Nanoparticles for Nanomedicines?, Chem. Rev. 122 (2022) 340-384. https://doi.org/10.1021/acs.chemrev.1c00484
[43] Q. Qiao, X. Liu, T. Yang, K. Cui, L. Kong, C. Yang, Z. Zhang, Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design, Acta Pharm. Sin. B 11 (2021) 3060-3091. https://doi.org/10.1016/j.apsb.2021.04.023
[44] M.N. Hafeez, C. Celia, V. Petrikaite, Challenges towards targeted drug delivery in cancer nanomedicines, Processes 9 (2021) 1-16. https://doi.org/10.3390/pr9091527
[45] L. Lu, Q. Xu, J. Wang, S. Wu, Z. Luo, W. Lu, Drug Nanocrystals for Active Tumor-Targeted Drug Delivery, Pharmaceutics 14 (2022) 1-23. https://doi.org/10.3390/pharmaceutics14040797
[46] W. Yang, B. Xia, L. Wang, S. Ma, H. Liang, D. Wang, J. Huang, Shape effects of gold nanoparticles in photothermal cancer therapy, Materials Today Sustainability 13 (2021) 1-11. https://doi.org/10.1016/j.mtsust.2021.100078
[47] S. Aftab, A. Shah, A. Nadhman, S. Kurbanoglu, S. Aysıl Ozkan, D.D. Dionysiou, S.S. Shukla, T.M. Aminabhavi, Nanomedicine: An effective tool in cancer therapy, Int. J. Pharm. 540 (2018) 132-149. https://doi.org/10.1016/j.ijpharm.2018.02.007
[48] H. Tariq, S.A.I. Bokhari, Surface-functionalised hybrid nanoparticles for targeted treatment of cancer, IET Nanobiotechnol. 14 (2020) 537-547. https://doi.org/10.1049/iet-nbt.2020.0073
[49] Ille C. Gebeshuber, G. Rose, A. Pavlicek, A. Gazsó, Bio-inspired and Biomimetic Nanomaterials, Nano Trust-Dossier 54 (2020) 1-6.
[50] I.C. Gebeshuber, Biomimetic Nanotechnology, Biomimetics 7 (2023) 1-5. https://doi.org/10.3390/biomimetics7010029
[51] M. Chen, Y. Sun, H. Liu, Cell membrane biomimetic nanomedicines for cancer phototherapy, Interdisciplinary Medicine 1 (2023) 1-24. https://doi.org/10.1002/INMD.20220012
[52] R. Prasad, V.G.S. Jyothi, N. Kommineni, R.T. Bulusu, B.B. Mendes, J.F. Lovell, J. Conde, Biomimetic Ghost Nanomedicine-Based Optotheranostics for Cancer, Nano. Lett. 24 (2024) 8217-8231. https://doi.org/10.1021/acs.nanolett.4c01534
[53] Y. Ji, Y. Wang, X. Wang, C. Lv, Q. Zhou, G. Jiang, B. Yan, L. Chen, Beyond the promise: Exploring the complex interactions of nanoparticles within biological systems, J. Hazard Mater. 468 (2024)133800. https://doi.org/10.1016/j.jhazmat.2024.133800
[54] M. Li, Q. Guo, C. Zhong, Z. Zhang, Multifunctional cell membranes-based nano-carriers for targeted therapies: a review of recent trends and future perspective, Drug Deliv. 30 (2023)1-25. https://doi.org/10.1080/10717544.2023.2288797
[55] Y.K. Gong, F.M. Winnik, Strategies in biomimetic surface engineering of nanoparticles for biomedical applications, Nanoscale 4 (2012) 360-368. https://doi.org/10.1039/C1NR11297J
[56] S.F. Ahmed, M. Mofijur, N. Rafa, A.T. Chowdhury, S. Chowdhury, M. Nahrin, A.B.M.S. Islam, H.C. Ong, Green approaches in synthesising nanomaterials for environmental nanobioremediation: Technological advancements, applications, benefits and challenges, Environ. Res. 204 (2022)1-11. https://doi.org/10.1016/j.envres.2021.111967
[57] R. Khalilov, A comprehensive review of advanced nano-biomaterials in regenerative medicine and drug delivery, Adv. in Bio. & Earth Sci. 8 (2023) 5-18.
[58] S.H. Loosen, B.E.O. Jensen, C. Tanislav, T. Luedde, C. Roderburg, K. Kostev, Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients, Infection 50 (2022) 1165-1170. https://doi.org/10.1007/s15010-022-01784-0
[59] N.G. Kotla, B. Chandrasekar, P. Rooney, G. Sivaraman, A. Larrañaga, K.V. Krishna, A. Pandit, Y. Rochev, Biomimetic Lipid-Based Nanosystems for Enhanced Dermal Delivery of Drugs and Bioactive Agents, ACS Biomater. Sci. Eng. 3 (2017) 1262-1272. https://doi.org/10.1021/acsbiomaterials.6b00681
[60] V. Makwana, J. Karanjia, T. Haselhorst, S. Anoopkumar-Dukie, S. Rudrawar, Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization, Int. J. Pharm. 593 (2021)1-14. https://doi.org/10.1016/j.ijpharm.2020.120117
[61] R. Fernández-García, A. Lalatsa, L. Statts, F. Bolás-Fernández, M.P. Ballesteros, D.R. Serrano, Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale, Int. J. Pharm. 573 (2020)1-45. https://doi.org/10.1016/j.ijpharm.2019.118817
[62] P.K. Kumar, R.S. Kumar, Review on Transferosomes and Transferosomal Gels, J. Pharm. Res. Int. (2021) 114-126. https://doi.org/10.9734/jpri/2021/v33i43B32532
[63] S.M. Mawazi, Y. Ge, R.T. Widodo, Niosome Preparation Techniques and Structure-An Illustrated Review, Pharmaceutics 17 (2025)1-39. https://doi.org/10.3390/pharmaceutics17010067
[64] G. Alam, S. Bali, A.P. Singh, N. Kumar Verma, A.K. Rai, Niosomes: An approach to current drug delivery-A Review, International Journal of Advances in Pharmaceutics 6 (2017) 41-48.
[65] M. Rageeb Md Usman, B. Vijaykumar Jain, P.R. Ghuge, B. V Jain, Niosomes: A novel trend of drug delivery, Research J. Pharm. and Tech 2018, 11, 5205-5211. https://doi.org/10.5958/0974-360X.2018.00950.2
[66] B. Lakic, C. Beh, S. Sarkar, S.L. Yap, P. Cardoso, C. Valery, A. Hung, N.C. Jones, S.V. Hoffmann, E.W. Blanch, B. Dyett, C.E. Conn, Cubosome lipid nanocarriers for delivery of ultra-short antimicrobial peptides, J. Colloid. Interface Sci. 677 (2025) 1080-1097. https://doi.org/10.1016/j.jcis.2024.07.232
[67] S. Ha, Y. La, K.T. Kim, Polymer Cubosomes: Infinite Cubic Mazes and Possibilities, Acc. Chem. Res. 53 (2020) 620-631. https://doi.org/10.1021/acs.accounts.9b00563
[68] D. Sivadasan, M.H. Sultan, S.S. Alqahtani, S. Javed, Cubosomes in Drug Delivery-A Comprehensive Review on Its Structural Components, Preparation Techniques and Therapeutic Applications, Biomedicines 11 (2023) 1-25. https://doi.org/10.3390/biomedicines11041114
[69] C.F. Grandes Reyes, S. Ha, K.T. Kim, Synthesis and applications of polymer cubosomes and hexosomes, J. Polym. Sci. 61 (2023) 1196-1213. https://doi.org/10.1002/pol.20230053
[70] J. Ma, C. Wu, G.W. Hart, Analytical and Biochemical Perspectives of Protein O-GlcNAcylation, Chem. Rev. 121 (2021) 1513-1581. https://doi.org/10.1021/acs.chemrev.0c00884
[71] H. Iqbal, T. Yang, T. Li, M. Zhang, H. Ke, D. Ding, Y. Deng, H. Chen, Serum protein-based nanoparticles for cancer diagnosis and treatment, J. Controlled Release 329 (2021) 997-1022. https://doi.org/10.1016/j.jconrel.2020.10.030
[72] R.C. Kines, C.D. Thompson, S. Spring, Z. Li, E. de los Pinos, S. Monks, J.T. Schiller, Virus-like particle-Drug conjugates induce protective, long-lasting adaptive antitumor immunity in the absence of specifically targeted tumor antigens, Cancer Immunol. Res. 9 (2021) 693-706. https://doi.org/10.1158/2326-6066.CIR-19-0974
[73] Y.S. Choi, H. Jang, B. Gupta, J.H. Jeong, Y. Ge, C.S. Yong, J.O. Kim, J.S. Bae, I.S. Song, I.S. Kim, Y.M. Lee, Tie2-mediated vascular remodeling by ferritin-based protein C nanoparticles confers antitumor and anti-metastatic activities, J. Hematol. Oncol. 13 (2020) 1-18. https://doi.org/10.1186/s13045-020-00952-9
[74] L. Van de Sande, S. Cosyns, W. Willaert, W. Ceelen, Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review, Drug Deliv. 27 (2020) 40-53. https://doi.org/10.1080/10717544.2019.1704945
[75] S. Linciano, G. Moro, A. Zorzi, A. Angelini, Molecular analysis and therapeutic applications of human serum albumin-fatty acid interactions, J. Controlled Release 348 (2022) 115-126. https://doi.org/10.1016/j.jconrel.2022.05.038
[76] C. Li, D. Zhang, Y. Pan, B. Chen, Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective, Polymers (Basel) 15 (2023) 1-18. https://doi.org/10.3390/polym15163354
[77] M. Plays, S. Müller, R. Rodriguez, Chemistry and biology of ferritin, Metallomics 13 (2021) 1-36. https://doi.org/10.1093/mtomcs/mfab021
[78] M. Kurzawa-Akanbi, M. Keogh, E. Tsefou, L. Ramsay, M. Johnson, S. Keers, L. WSA Ochieng, A. McNair, P. Singh, A. Khan, A. Pyle, G. Hudson, P.G. Ince, J. Attems, J. Burn, P.F. Chinnery, C.M. Morris, Neuropathological and biochemical investigation of Hereditary Ferritinopathy cases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative stress, Neuropathol. Appl. Neurobiol. 47 (2021) 26-42. https://doi.org/10.1111/nan.12634
[79] S. Levi, M. Ripamonti, M. Dardi, A. Cozzi, P. Santambrogio, Mitochondrial ferritin: Its role in physiological and pathological conditions, Cells 10 (2021) 1-14. https://doi.org/10.3390/cells10081969
[80] Y. Zhu, Y. Zhu, T. Cao, X. Liu, X. Liu, Y. Yan, Y. Shi, J.C. Wang, Ferritin-based nanomedicine for disease treatment, Medical Review 3 (2023) 49-74. https://doi.org/10.1515/mr-2023-0001
[81] L. Liu, X. Bai, M.V. Martikainen, A. Kårlund, M. Roponen, W. Xu, G. Hu, E. Tasciotti, V.P. Lehto, Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles, Nat. Commun. 12 (2021) 1-11. https://doi.org/10.1038/s41467-021-26052-x
[82] L. Zhu, Y. Zhong, S. Wu, M. Yan, Y. Cao, N. Mou, G. Wang, D. Sun, W. Wu, Cell membrane camouflaged biomimetic nanoparticles: Focusing on tumor theranostics, Mater. Today Bio. 14 (2022) 1-16. https://doi.org/10.1016/j.mtbio.2022.100228
[83] S. qi Zhang, Q. Fu, Y. jie Zhang, J. xing Pan, L. Zhang, Z. rong Zhang, Z. mi Liu, Surface loading of nanoparticles on engineered or natural erythrocytes for prolonged circulation time: strategies and applications, Acta Pharmacol. Sin. 42 (2021) 1040-1054. https://doi.org/10.1038/s41401-020-00606-z
[84] H. Liu, Y. Li, Y. Wang, L. Zhang, X. Liang, C. Gao, Y. Yang, Red blood cells-derived components as biomimetic functional materials: Matching versatile delivery strategies based on structure and function, Bioact. Mater. 47 (2025) 481-501. https://doi.org/10.1016/j.bioactmat.2025.01.021
[85] J. Ding, X. Ding, W. Liao, Z. Lu, Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications, Mater. Today Bio 24 (2024) 1-33. https://doi.org/10.1016/j.mtbio.2023.100913
[86] Q. Guo, Z.M. Qian, Macrophage based drug delivery: Key challenges and strategies, Bioact. Mater. 38 (2024) 55-72. https://doi.org/10.1016/j.bioactmat.2024.04.004
[87] W. Song, P. Jia, Y. Ren, J. Xue, B. Zhou, X. Xu, Y. Shan, J. Deng, Q. Zhou, Engineering white blood cell membrane-camouflaged nanocarriers for inflammation-related therapeutics, Bioact. Mater. 23 (2023) 80-100. https://doi.org/10.1016/j.bioactmat.2022.10.026
[88] N. Khosravi, E. Pishavar, B. Baradaran, F. Oroojalian, A. Mokhtarzadeh, Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics, J. Control. Release 348 (2022) 706-722. https://doi.org/10.1016/j.jconrel.2022.06.026
[89] W. Zhang, X. Huang, Stem cell membrane-camouflaged targeted delivery system in tumor, Mater. Today Bio 16 (2022) 1-10. https://doi.org/10.1016/j.mtbio.2022.100377
[90] Z. Xia, W. Mu, S. Yuan, S. Fu, Y. Liu, N. Zhang, Cell membrane biomimetic nano-delivery systems for cancer therapy, Pharmaceutics 15 (2023) 1-26. https://doi.org/10.3390/pharmaceutics15122770
[91] H. Shen, Y. Ouyang, L. Zhang, J. Li, S. Wang, Blood Cell Membrane-Coated Nanomaterials as a Versatile Biomimetic Nanoplatform for Antitumor Applications, Nanomaterials 14 (2024) 1-21. https://doi.org/10.3390/nano14211757
[92] A. Bezze, C. Mattioda, G. Ciardelli, C. Mattu, Harnessing cells to improve transport of nanomedicines, European Journal of Pharmaceutics and Biopharmaceutics 203 (2024) 1-16. https://doi.org/10.1016/j.ejpb.2024.114446
[93] D. Chenthamara, S. Subramaniam, S.G. Ramakrishnan, S. Krishnaswamy, M.M. Essa, F.H. Lin, M.W. Qoronfleh, Therapeutic efficacy of nanoparticles and routes of administration, Biomater. Res. 23 (2019) 1-29. https://doi.org/10.1186/s40824-019-0166-x
[94] C. Guido, G. Maiorano, B. Cortese, S. D’amone, I.E. Palamà, Biomimetic nanocarriers for cancer target therapy, Bioengineering 7 (2020) 1-16. https://doi.org/10.3390/bioengineering7030111
[95] X. Ma, Z. Luan, J. Li, Inorganic Nanoparticles-Based Systems in Biomedical Applications of Stem Cells: Opportunities and Challenges, Int J Nanomedicine 18 (2023) 143-182. https://doi.org/10.2147/IJN.S384343
[96] H. Montaseri, C.A. Kruger, H. Abrahamse, Inorganic nanoparticles applied for active targeted photodynamic therapy of breast cancer, Pharmaceutics 13 (2021) 1-33. https://doi.org/10.3390/pharmaceutics13030296
[97] K. Kobayashi, J. Wei, R. Iida, K. Ijiro, K. Niikura, Surface engineering of nanoparticles for therapeutic applications, Polym J 46 (2014) 460-468. https://doi.org/10.1038/pj.2014.40
[98] S. Gavas, S. Quazi, T.M. Karpiński, Nanoparticles for Cancer Therapy: Current Progress and Challenges, Nanoscale Res Lett 16 (2021)1-21. https://doi.org/10.1186/s11671-021-03628-6
[99] Y. Zhang, Q. Chen, Y. Zhu, M. Pei, K. Wang, X. Qu, Y. Zhang, J. Gao, H. Qin, Targeting inorganic nanoparticles to tumors using biological membrane-coated technology, MedComm (Beijing) 3 (2022)1-19. https://doi.org/10.1002/mco2.192
[100] R. Rampado, P. Caliceti, M. Agostini, Latest Advances in Biomimetic Cell Membrane-Coated and Membrane-Derived Nanovectors for Biomedical Applications, Nanomaterials 12 (2022)1-25. https://doi.org/10.3390/nano12091543
[101] Y. Zhang, J. Wang, Research progress of cell membrane biomimetic nanoparticles for circulating tumor cells, Front Oncol 14 (2024)1-30. https://doi.org/10.3389/fonc.2024.1389775
[102] H. Liu, Y.Y. Su, X.C. Jiang, J.Q. Gao, Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system, Drug Deliv Transl Res 13 (2023) 716-737. https://doi.org/10.1007/s13346-022-01252-0
[103] S. Alimohammadvand, M. Kaveh Zenjanab, M. Mashinchian, J. Shayegh, R. Jahanban-Esfahlan, Recent advances in biomimetic cell membrane-camouflaged nanoparticles for cancer therapy, Biomedicine and Pharmacotherapy 177 (2024)1-24. https://doi.org/10.1016/j.biopha.2024.116951
[104] P. Graván, J.A. Marchal, F. Galisteo-González, Improving tumor treatment: Cell membrane-coated nanoparticles for targeted therapies, Mater Today Bio 32 (2025)1-22. https://doi.org/10.1016/j.mtbio.2025.101716
[105] M. Solomon, Y. Liu, M.Y. Berezin, S. Achilefu, Optical imaging in cancer research: Basic principles, tumor detection, and therapeutic monitoring, Medical Principles and Practice 20 (2011) 397-415. https://doi.org/10.1159/000327655
[106] C. Kaittanis, T.M. Shaffer, D.L.J. Thorek, J. Grimm, Dawn of advanced molecular medicine: Nanotechnological advancements in cancer imaging and therapy, 19 (2014) 143-176. https://doi.org/10.1615/CritRevOncog.2014011601
[107] E. Szliszka, Z.P. Czuba, M. Domino, B. Mazur, G. Zydowicz, W. Krol, Ethanolic extract of propolis (EEP) enhances the apoptosis- inducing potential of TRAIL in cancer cells, Molecules 14 (2009) 738-754. https://doi.org/10.3390/molecules14020738
[108] H. Mengyuan, L. Aixue, G. Yongwei, C. Qingqing, C. Huanhuan, L. Xiaoyan, L. Jiyong, Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication, J Nanobiotechnology 22 (2024) 1-29. https://doi.org/10.1186/s12951-024-02835-4
[109] S. Qiu, F. Zhu, L. Tong, Application of targeted drug delivery by cell membrane-based biomimetic nanoparticles for inflammatory diseases and cancers, Eur J Med Res 29 (2024) 1-15. https://doi.org/10.1186/s40001-024-02124-8
[110] T. Wang, H. Zhang, W. Qiu, Y. Han, H. Liu, Z. Li, Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy, Bioact Mater 16 (2022) 418-432. https://doi.org/10.1016/j.bioactmat.2021.12.029
[111] A.G. Mukherjee, U.R. Wanjari, A. Namachivayam, R. Murali, D.S. Prabakaran, R. Ganesan, K. Renu, A. Dey, B. Vellingiri, G. Ramanathan, G.P. Doss C, A.V. Gopalakrishnan, Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach, Vaccines (Basel) 10 (2022) 1-21. https://doi.org/10.3390/vaccines10091493
[112] Y.Y. Zeng, Q. Gu, D. Li, A.X. Li, R.M. Liu, J.Y. Liang, J.Y. Liu, Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy, Acta Pharmacol Sin 45 (2024)2455-2473. https://doi.org/10.1038/s41401-024-01355-z
[113] C. Lee Ventola, Cancer Immunotherapy, Part 3: Challenges and Future Trends, Pharmacy and Therapeutics 42 (2017) 514 -521.
[114] H. Yu, M. Wu, S. Chen, M. Song, Y. Yue, Biomimetic nanoparticles for tumor immunotherapy, Front Bioeng Biotechnol. 10 (2022) 1-17. https://doi.org/10.3389/fbioe.2022.989881
[115] M. Sushnitha, M. Evangelopoulos, E. Tasciotti, F. Taraballi, Cell membrane-based biomimetic nanoparticles and the immune system: Immunomodulatory interactions to therapeutic applications, Front Bioeng Biotechnol. 8 (2020) 1-17. https://doi.org/10.3389/fbioe.2020.00627
[116] Y. Yu, W. Li, Q. Yu, J. Ye, H. Wang, Y. Li, S. Yin, Biomimetic-Nanoparticle-Enhanced Photothermal Immunotherapy: Targeted Delivery of Near-Infrared Region II Agents and Immunoadjuvants for Tumor Immunogenicity, Biomater Res 29 (2025) 1-18. https://doi.org/10.34133/bmr.0151
[117] J.H. Correia, J.A. Rodrigues, S. Pimenta, T. Dong, Z. Yang, Photodynamic therapy review: Principles, photosensitizers, applications, and future directions, Pharmaceutics 13 (2021) 1-16. https://doi.org/10.3390/pharmaceutics13091332
[118] S. Kwiatkowski, B. Knap, D. Przystupski, J. Saczko, E. Kędzierska, K. Knap-Czop, J. Kotlińska, O. Michel, K. Kotowski, J. Kulbacka, Photodynamic therapy – mechanisms, photosensitizers and combinations, Biomedicine and Pharmacotherapy 106 (2018) 1098-1107. https://doi.org/10.1016/j.biopha.2018.07.049
[119] X. Deng, Z. Shao, Y. Zhao, Solutions to the Drawbacks of Photothermal and Photodynamic Cancer Therapy, Advanced Science 8 (2021)1-16. https://doi.org/10.1002/advs.202002504
[120] A. Zinger, Unleashing the potential of cell biomimetic nanoparticles: Strategies and challenges in their design and fabrication for therapeutic applications, Journal of Controlled Release 358 (2023) 591-600. https://doi.org/10.1016/j.jconrel.2023.04.040
[121] Y. Huang, X. Guo, Y. Wu, X. Chen, L. Feng, N. Xie, G. Shen, Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment, Signal Transduct Target Ther 9 (2024)1-50. https://doi.org/10.1038/s41392-024-01745-z
[122] L. Farhoudi, S.F. Fobian, A.L. Oei, M. Amin, M.R. Jaafari, T.L.M. ten Hagen, Applications of biomimetic nanoparticles in breast cancer as a blueprint for improved next-generation cervical cancer therapy, Nano Today 53 (2023)1-18. https://doi.org/10.1016/j.nantod.2023.102032
[123] D. Mundekkad, A.R. Mallya, Biomimicry at the nanoscale – a review of nanomaterials inspired by nature, Nano Trends 10 (2025)1-17. https://doi.org/10.1016/j.nwnano.2025.100119